SG11201806361PA - Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation - Google Patents

Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation

Info

Publication number
SG11201806361PA
SG11201806361PA SG11201806361PA SG11201806361PA SG11201806361PA SG 11201806361P A SG11201806361P A SG 11201806361PA SG 11201806361P A SG11201806361P A SG 11201806361PA SG 11201806361P A SG11201806361P A SG 11201806361PA SG 11201806361P A SG11201806361P A SG 11201806361PA
Authority
SG
Singapore
Prior art keywords
prevention
treatment
faecalibacterium prausnitzii
gastrointestinal inflammation
strain cncm
Prior art date
Application number
SG11201806361PA
Inventor
Philippe Langella
Rosique Rebeca Martin
Humaran Luis Bermudez
Florian Chain
Harry Sokol
Original Assignee
Inst Nat De La Rech Agronomique Inra
Univ Sorbonne
Hopitaux Paris Assist Publique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat De La Rech Agronomique Inra, Univ Sorbonne, Hopitaux Paris Assist Publique filed Critical Inst Nat De La Rech Agronomique Inra
Publication of SG11201806361PA publication Critical patent/SG11201806361PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573 FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION The invention relates to a bacterial strain of species Faecalibacterium prausnitzii deposited at the CNCM under access number CNCM I-4573, for use in the treatment and/or prevention of an inflammatory gastrointestinal illness in an individual. [No Suitable Figure]
SG11201806361PA 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation SG11201806361PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1650567A FR3046934B1 (en) 2016-01-25 2016-01-25 FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573 FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION
PCT/EP2017/051306 WO2017129515A1 (en) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation

Publications (1)

Publication Number Publication Date
SG11201806361PA true SG11201806361PA (en) 2018-08-30

Family

ID=55862967

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201806361PA SG11201806361PA (en) 2016-01-25 2017-01-23 Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation

Country Status (18)

Country Link
US (1) US10918678B2 (en)
EP (1) EP3407902B1 (en)
JP (1) JP6935632B2 (en)
CN (1) CN109310714A (en)
AU (1) AU2017211244B2 (en)
BR (1) BR112018015121A2 (en)
CA (1) CA3012214A1 (en)
ES (1) ES2820338T3 (en)
FR (1) FR3046934B1 (en)
HU (1) HUE050810T2 (en)
IL (1) IL260752B (en)
LT (1) LT3407902T (en)
NZ (1) NZ744528A (en)
PL (1) PL3407902T3 (en)
PT (1) PT3407902T (en)
SG (1) SG11201806361PA (en)
WO (1) WO2017129515A1 (en)
ZA (1) ZA201805302B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111107860A (en) * 2017-06-16 2020-05-05 表飞鸣制药株式会社 Prophylactic or therapeutic agent for fat-related disease and/or inflammation
FR3084255B1 (en) * 2018-07-26 2020-07-03 Institut National De La Recherche Agronomique (Inra) STREPTOCOCCUS THERMOPHILUS CNRZ160 STRAIN FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATION AND RELATED DISORDERS IN AN INDIVIDUAL
FR3099053B1 (en) * 2019-07-24 2023-01-20 Inst Nat De La Rech Agronomique Inra BACTERIAL STRAINS FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION
EP3838276A1 (en) 2019-12-17 2021-06-23 Exeliom Biosciences Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation
KR102169795B1 (en) 2020-06-24 2020-10-27 주식회사 엔테로바이옴 Novel Faecalibacterium prausnitzii EB-FPDK9 and Use Thereof
KR102169794B1 (en) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 Novel Faecalibacterium prausnitzii EB-FPDK11 and Use Thereof
CN116529355A (en) * 2020-08-14 2023-08-01 Ko生物技术有限公司 Probiotics praecox strain and application thereof
EP4219681A1 (en) * 2020-09-28 2023-08-02 CJ Bioscience, Inc. Composition for diagnosis or treatment of inflammatory diseases, comprising microorganism
CN112402459B (en) * 2020-10-27 2023-01-31 江南大学 Application of clostridium pralatum in relieving allergic asthma and rhinitis Th2 reaction
KR102245415B1 (en) * 2020-12-14 2021-04-29 주식회사 엔테로바이옴 The Composition of Culture Media for Faecalibacterium prausnitzii
EP4166150A1 (en) 2021-10-15 2023-04-19 Exeliom Biosciences Association of a faecalibacterium prausnitzii strain and anti-pd-1, anti-pd-l1 or anti-ctla-4 antibodies for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2988761A1 (en) * 2013-03-05 2016-03-02 Rijksuniversiteit Groningen Use of faecali bacterium prausnitzii htf-f (dsm 26943) to suppress inflammation.
HUE049340T2 (en) * 2014-11-13 2020-09-28 Institut National De La Rech Pour Lagriculture Lalimentation Et Lenvironnement Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain

Also Published As

Publication number Publication date
EP3407902B1 (en) 2020-07-15
LT3407902T (en) 2020-12-28
HUE050810T2 (en) 2021-01-28
ES2820338T3 (en) 2021-04-20
AU2017211244A1 (en) 2018-08-09
ZA201805302B (en) 2019-10-30
JP6935632B2 (en) 2021-09-15
BR112018015121A2 (en) 2018-12-11
US10918678B2 (en) 2021-02-16
EP3407902A1 (en) 2018-12-05
US20190030089A1 (en) 2019-01-31
PT3407902T (en) 2020-09-03
CA3012214A1 (en) 2017-08-03
CN109310714A (en) 2019-02-05
AU2017211244B2 (en) 2019-05-16
PL3407902T3 (en) 2021-04-06
IL260752B (en) 2021-02-28
NZ744528A (en) 2020-02-28
FR3046934A1 (en) 2017-07-28
FR3046934B1 (en) 2018-01-26
WO2017129515A1 (en) 2017-08-03
JP2019508486A (en) 2019-03-28

Similar Documents

Publication Publication Date Title
SG11201806361PA (en) Faecalibacterium prausnitzii strain cncm 1-4573 for the treatment and prevention of gastrointestinal inflammation
MX2021000077A (en) Compositions comprising bacterial strains.
MX2018006239A (en) Compositions comprising bacterial strains.
MX2018006399A (en) Compositions comprising bacterial strains.
MX2017016529A (en) Compositions comprising bacterial strains.
MX2017016564A (en) Compositions comprising bacterial strains.
MX2017016560A (en) Compositions comprising bacterial strains.
MX2017016525A (en) Compositions comprising bacterial strains.
MX2016002765A (en) Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid.
UA113059C2 (en) ANTIMicrobial composition based on LACTOBACILLUS RHAMNOSUS, LACTOBACILLUS PARACASEI strains
UA109123C2 (en) PROBIOTIC COMPOSITION FOR THE APPLICATION IN THE TREATMENT OF INTESTINAL INFLAMMATION
NZ712959A (en) Probiotic strains for use in treatment or prevention of osteoporosis
MX2015000338A (en) Novel strain of lactobacillus crispatus.
IN2012DN01911A (en)
WO2016172204A8 (en) Multiplex detection of vulvovaginal candidiasis, trichomoniasis and bacterial vaginosis
SI3218524T1 (en) Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain
UA118339C2 (en) A method for selection of agents influencing intestinal motility disorders and pain
PH12017502042A1 (en) Dietary supplement
EP3406709A4 (en) Differentiation induction from human pluripotent stem cells into hypothalamic neurons
GEP20207089B (en) Histamine-producing bacterial strains and their use in cancer
MX2017007969A (en) Lactic acid bacteria and their use for the treatment of mastitis.
MX2016008971A (en) Methods of detecting and quantifiying bacteria contained on or within chewing gum.
WO2016027029A3 (en) Method for determining the survival prognosis of a patient suffering from pancreatic cancer
MX2014001572A (en) New strain of l. bulgaricus capable of inhibiting the adhesion of h. pylori strains to epithelial cells.
ZA202206998B (en) Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation